stay up to date on this topic
researchers analyzed the data of 21,618 adults in the u.s.-wide population assessment of tobacco and health survey from 2013 to 2018. the participants had no self-reported respiratory issues and the scientists adjusted for a variety of variables including age, marijuana use and secondhand smoke exposure. the analysis was also restricted to adults who never smoked cigarettes or used tobacco products such as hookahs, cigars, cigarillos and smokeless tobacco.
the results,
published in the jama network open, suggests individuals who vaped or used e-cigarettes in the past were 21 per cent more likely to develop a respiratory disease. those who were currently e-cigarette users saw a 43 per cent increased risk. in fact, this group saw a 33 per cent increase in chronic bronchitis risk, 69 per cent increase in emphysema risk, 57 per cent increase in chronic obstructive pulmonary disease (copd) risk, and 31 per cent percent increase in asthma risk.
dr. andrew stokes, assistant professor of global health at busph, says the study offers some of the very first longitudinal evidence that vaping can have a serious impact on the respiratory system.
“in recent years, we have seen dramatic increase in e-cigarette use among youth and young adults which threatens to reverse decades of hard-fought gains,” he says. “this new evidence also suggests that we may see an increase in respiratory disease as youth and young adults age into midlife, including asthma, copd, and other respiratory conditions.”
in 2018, the u.s. centers for disease control
investigated a national outbreak of more than 2,800 cases of e-cigarette, or vaping, product use-associated lung injury (evali). the cases were linked to products that contained tetrahydrocannabinol (thc) and vitamin e acetate, an additive or cutting agent, and were often acquired through dealers or informal sources.